LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) Operating income 2016–2025
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) annual operating income history from SEC filings — each fiscal year as reported.
$41.0MFY2025 · since FY2016: $43.9M → $41.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $41.0M | +281.4% |
| FY2024 | -$22.6M | -289.3% |
| FY2023 | $11.9M | +293.2% |
| FY2022 | $3.0M | -97.1% |
| FY2021 | $103.9M | +176.9% |
| FY2020 | $37.5M | -95.4% |
| FY2019 | $807.1M | +392.9% |
| FY2018 | $163.7M | +140.5% |
| FY2017 | $68.1M | +55.1% |
| FY2016 | $43.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice